Skip to main content

Peer Review reports

From: Efficacy and safety of baricitinib in rheumatoid arthritis patients with moderate renal impairment: a multicenter propensity score matching study

Original Submission
2 Aug 2024 Submitted Original manuscript
30 Aug 2024 Reviewed Reviewer Report
1 Sep 2024 Reviewed Reviewer Report - Gikas Katsifis
22 Sep 2024 Reviewed Reviewer Report
1 Nov 2024 Author responded Author comments - Akira Maeyama
Resubmission - Version 2
1 Nov 2024 Submitted Manuscript version 2
18 Nov 2024 Reviewed Reviewer Report - Gikas Katsifis
19 Nov 2024 Reviewed Reviewer Report
3 Dec 2024 Author responded Author comments - Akira Maeyama
Resubmission - Version 3
3 Dec 2024 Submitted Manuscript version 3
Publishing
6 Dec 2024 Editorially accepted
18 Dec 2024 Article published 10.1186/s41927-024-00446-y

You can find further information about peer review here.

Back to article page